product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
JARID1B Antibody
catalog :
3273
clonality :
polyclonal
host :
rabbit
conjugate :
nonconjugated
reactivity :
human
application :
western blot, immunoprecipitation
citations: 3
Published Application/Species/Sample/DilutionReference
  • western blot; human; fig 6
Huang C, Cheng J, Bawa Khalfe T, Yao X, Chin Y, Yeh E. SUMOylated ORC2 Recruits a Histone Demethylase to Regulate Centromeric Histone Modification and Genomic Stability. Cell Rep. 2016;15:147-157 pubmed publisher
  • western blot; human; 1:1000; fig 3k
Nilsson E, Laursen K, Whitchurch J, McWilliam A, Ødum N, Persson J, et al. MiR137 is an androgen regulated repressor of an extended network of transcriptional coregulators. Oncotarget. 2015;6:35710-25 pubmed publisher
Nijwening J, Geutjes E, Bernards R, Beijersbergen R. The histone demethylase Jarid1b (Kdm5b) is a novel component of the Rb pathway and associates with E2f-target genes in MEFs during senescence. PLoS ONE. 2011;6:e25235 pubmed publisher
product information
SKU :
3273S
Product-Name :
JARID1B Antibody
Size :
100 ul
Price-(USD) :
235 USD
Species-x-Reactivity :
H, Mk
Applications :
Immunoprecipitation
Product-Category :
Chromatin Regulation / Nuclear Function
Shipping-Temp :
AMBIENT
Storage-Temp :
-20°C
Product-Type :
Polyclonal Antibody
MW :
180
Host :
Rabbit
Target :
JARID1B
Primary-Protein :
JARID1B
Alt-Names :
CT31,Cancer/testis antigen 31,FLJ10538,FLJ12459,FLJ12491,FLJ16281,FLJ23670,Histone demethylase JARID1B,JARID1B,Jumonji/ARID domain-containing protein 1B,KDM5B,Lysine-specific demethylase 5B,PLU-1,PLU1,PUT1,RBBP2H1,RBBP2H1A,RBP2-H1,RBP2-like,Retinoblastoma-binding protein 2 homolog 1,jumonji, AT rich interactive domain 1B,lysine (K)-specific demethylase 5B,putative DNA/chromatin binding motif,retinoblastoma-binding protein 2, homolog 1A
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.